Return to List
Results 1–4 of 4
Title Date
1.

Depot Medroxyprogesterone Acetate and Bone Effects

Number 602

(Replaces Committee Opinion Number 415, September 2008)

ABSTRACT: Depot medroxyprogesterone acetate (DMPA) is a highly effective injectable contraceptive that affords privacy and has a convenient dose schedule of four times per year, making it appealing t...

June 2014

PDF Format
2.

Adolescent Confidentiality and Electronic Health Records

Number 599

Abstract: Confidentiality concerns are heightened during adolescence, and these concerns can be a critical barrier to adolescents in receiving appropriate health care. Health care providers caring fo...

May 2014

PDF Format
3.

The Initial Reproductive Health Visit

Number 598

(Replaces Committee Opinion Number 460, July 2010)

Abstract: The initial visit for screening and the provision of reproductive preventive health care services and guidance should take place between the ages of 13 years and 15 years. The initial repro...

May 2014

PDF Format
4.

Human Papillomavirus Vaccination

Number 588

(Replaces Committee Opinion Number 467, September 2010)

ABSTRACT: The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention recommends that human papillomavirus (HPV) vaccination routinely be targeted to females an...

March 2014

PDF Format